Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly FCF Margin of 2.6% for Q2 2026, up 15638.0% year-over-year from N/an in Q2 2025, and up 90.42% quarter-over-quarter from 27.13% in Q1 2026.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported FCF Margin for 4 consecutive years, with 2.6% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin rose 15638.0% year-over-year to 2.6%; the TTM figure through Jun 2026 stood at 15.84% (up 22517.0% YoY), while the FY2025 annual figure was 95.94%, up 38713.0% from the prior year.
- FCF Margin grew to 2.6% in Q2 2026 per PHAT's latest filing, from 27.13% in the prior quarter.
- Across five years, FCF Margin topped out at 2.6% in Q2 2026 and bottomed at 6155.57% in Q4 2023.
- Historically, FCF Margin has averaged 1078.41% across 4 years, with a median of 213.93% in 2024.
- Annual changes were most pronounced in 2024 — FCF Margin soared 594164 bps — and 2026, when it surged 15638 bps.
- Phathom Pharmaceuticals' FCF Margin stood at 6155.57% in 2023, then jumped by 97 bps to 213.93% in 2024, then jumped by 95 bps to 10.56% in 2025, then jumped by 75 bps to 2.6% in 2026.
- Business Quant data shows PHAT's FCF Margin at 2.6% in Q2 2026, 27.13% in Q1 2026, and 10.56% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Phathom Pharmaceuticals | 796.85 Mn | 611.51 Mn | 59.18 Mn | -2.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.60% |
| Mar 31, 2026 | -27.13% |
| Dec 31, 2025 | -10.56% |
| Sep 30, 2025 | -28.57% |
| Jun 30, 2025 | -158.98% |
| Mar 31, 2025 | -297.96% |
| Dec 31, 2024 | -213.93% |
| Sep 30, 2024 | -389.05% |
| Jun 30, 2024 | -966.23% |
| Mar 31, 2024 | -3,611.92% |
| Dec 31, 2023 | -6,155.57% |